Hemodynamic effects of calcium-sensitizing agents
Over the last few years the development of calcium-sensitizing agents has led to a new approach to the treatment of congestive heart failure (CHF). These novel inotropic agents act directly on the contractile protein systems and correct the reduced responsiveness of the myofilaments to calcium. The...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
1995
|
| Sorozat: | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
26 No. Suppl. 1 |
| Tárgyszavak: | |
| doi: | 10.1097/00005344-199506261-00004 |
| mtmt: | 1131787 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/32583 |
| LEADER | 01656nab a2200265 i 4500 | ||
|---|---|---|---|
| 001 | publ32583 | ||
| 005 | 20250312152753.0 | ||
| 008 | 250312s1995 hu o 000 eng d | ||
| 022 | |a 0160-2446 | ||
| 024 | 7 | |a 10.1097/00005344-199506261-00004 |2 doi | |
| 024 | 7 | |a 1131787 |2 mtmt | |
| 040 | |a SZTE Publicatio Repozitórium |b hun | ||
| 041 | |a eng | ||
| 100 | 1 | |a Végh Ágnes | |
| 245 | 1 | 0 | |a Hemodynamic effects of calcium-sensitizing agents |h [elektronikus dokumentum] / |c Végh Ágnes |
| 260 | |c 1995 | ||
| 300 | |a 12 | ||
| 300 | |a S20-S31 | ||
| 490 | 0 | |a JOURNAL OF CARDIOVASCULAR PHARMACOLOGY |v 26 No. Suppl. 1 | |
| 520 | 3 | |a Over the last few years the development of calcium-sensitizing agents has led to a new approach to the treatment of congestive heart failure (CHF). These novel inotropic agents act directly on the contractile protein systems and correct the reduced responsiveness of the myofilaments to calcium. The resultant favorable inotropic activity of this new class of cardiotonic agents may represent an important pharmacologic approach to the future treatment of acute and chronic CHF. This brief review summarizes the cardiotonic effects of calcium sensitizers, with particular emphasis on the hemodynamic actions of these drugs in various in vitro and in vivo heart preparations. We also attempt to draw conclusions for the therapeutic exploitation of these agents and delineate their possible role in the therapy of CHF. | |
| 650 | 4 | |a Klinikai orvostan | |
| 700 | 0 | 1 | |a Papp Gyula |e aut |
| 700 | 0 | 1 | |a Udvary Éva |e aut |
| 700 | 0 | 1 | |a Kaszala Károly |e aut |
| 856 | 4 | 0 | |u http://publicatio.bibl.u-szeged.hu/32583/1/aok_klny_807_95.pdf |z Dokumentum-elérés |